Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia
Pennsylvania
19111-2497
United States
Tel: 888-369-2427
Website: http://www.fccc.edu/
103 articles about Fox Chase Cancer Center
-
Beatrice Mintz, the research legend passed away at the age of 100. Her contribution to the field is unforgettable. ere's more about her and the research.
-
Now, researchers are on the threshold of great changes that have the potential to transform non-curable diseases into those that can be cured.
-
Heading out of November and into December, plenty of companies had clinical trial news to report. Here’s a look.
-
Lantern Pharma Announces Collaboration and Research Agreement with Fox Chase Cancer Center Focused on Advancing the Development of LP-184 in Pancreatic Cancer
9/22/2020
Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR ® artificial intelligence ("A.I.") platform to improve drug discovery & development and identify patients who will benefit from its targeted oncology therapeutics, today announced a collaboration and research agreement with Fox Chase Cancer
-
Genome Profiling, Fox Chase Cancer Center to Collaborate on Immune System Blood Test to Predict Checkpoint Inhibitor Response in Non-Small Cell Lung Cancer
7/21/2020
Genome Profiling and Fox Chase Cancer Center will collaborate to identify a novel immune system epigenetic biomarker, dubbed EpiMarker, which if successful, will be used to help predict which lung cancer patients are likely to respond to a checkpoint inhibitor therapy known as anti-PD1 antibody.
-
MORE Health Announces Partnership with Fox Chase Cancer Center to offer Patients Remote Second Opinions
2/19/2019
Fox Chase Cancer Center and MORE Health, a global healthcare company, announced a cutting-edge partnership that gives patients from across the world access to the nationally ranked physicians of Fox Chase Cancer Center through MORE Health's Physician Collaboration Platform™.
-
Natera and Fox Chase Cancer Center to Collaborate on Kidney Cancer Study
8/15/2018
Natera, Inc. has partnered with Fox Chase Cancer Center to assess the company's Signatera™ customized circulating tumor DNA assay for recurrence monitoring of kidney cancer.
-
Clinical Cancer Research Article Describes Opportunity to Use Imipridones for Brain Tumors
7/31/2018
Oncoceutics, Inc. announced the publication of a scientific research article in the journal Clinical Cancer Research that demonstrates utility for the company’s imipridone portfolio of compounds in neuro-oncology.
-
Fox Chase Cancer Center Researchers Seek Breast Cancer Biomarkers That Indicate Immunotherapy Responsiveness
12/8/2017
A small, but significant proportion of patients with invasive breast cancer have at least one of three biomarkers linked to ICB therapy, suggesting a role for such treatment for certain breast cancers, a new study shows.
-
GlaxoSmithKline’s Jerry Adams Joins Fox Chase Cancer Center As Visiting Professor
9/13/2017
-
ReproCELL And Fox Chase Cancer Center Partner To Open Multi-Site Biosample Repository In India
5/25/2017
-
Oncoceutics Release: Fox Chase Cancer Center Enrolling Patients In ONC201 Multiple Myeloma Trial
5/1/2017
-
ReproCELL And Fox Chase Cancer Center Form Strategic Alliance To Accelerate Biomarker And Genetic Discovery
4/13/2017
-
ERYtech Pharma Collaborates With Fox Chase Cancer Center To Advance Its Platform In The Field Of Rare Metabolic Disorders
3/23/2017
-
Fox Chase Cancer Center Study: Pancreatic And Kidney Cancers Contain Noncancerous Niches That May Be Manipulated To Hinder Tumor Growth
1/31/2017
-
Morphotek Announces Sponsored Research Agreement With Fox Chase Cancer Center To Study Immunosuppressive Effects Of Tumor Shed Antigens To Improve Future Patient Therapies
9/13/2016
-
Fox Chase Cancer Center Researchers Use New Methodology To Identify Neighborhood Variables Associated With Prostate Cancer Aggressiveness
4/15/2016
-
Review By Fox Chase Cancer Center -- Temple Health And Temple University School Of Medicine Physicians Highlights Advances In Diagnosis And Treatment Of Bile Ducts Cancers
1/22/2016
-
Caris Life Sciences And Fox Chase Cancer Center - Temple Health Collaborate On Potential New Treatments For Triple-Negative Breast Cancer (TNBC)
12/8/2015
-
Oncoceutics Release: Clinical Trial For ONC201 Begins At Fox Chase Cancer Center
11/30/2015